Roche Holding AG
SIX:ROG
Roche Holding AG
Depreciation & Amortization
Roche Holding AG
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Depreciation & Amortization
CHf3.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
Novartis AG
SIX:NOVN
|
Depreciation & Amortization
$7.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
17%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Depreciation & Amortization
$10k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Depreciation & Amortization?
Depreciation & Amortization
3.5B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Depreciation & Amortization amounts to 3.5B CHF.
What is Roche Holding AG's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
4%
Over the last year, the Depreciation & Amortization growth was -10%. The average annual Depreciation & Amortization growth rates for Roche Holding AG have been -9% over the past three years , -1% over the past five years , and 4% over the past ten years .